Valuation : Biogen Inc.

Market Cap 32.28B 27.82B 26.08B 23.81B 44.86B 3,086B 45B 309B 121B 1,558B 121B 119B 5,165B P/E 2026 *
38.8x
P/E 2027 * 19.1x
Enterprise Value 37.22B 32.07B 30.07B 27.45B 51.71B 3,557B 51.88B 357B 139B 1,796B 140B 137B 5,954B EV / Sales 2026 *
3.56x
EV / Sales 2027 * 3.26x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day-1.35%
1 week+0.79%
Current month+7.66%
1 month+6.27%
3 months+11.26%
6 months+13.91%
Current year+24.15%
1 week 213.96
Extreme 213.96
222.85
1 month 199.58
Extreme 199.58
222.85
Current year 160.36
Extreme 160.3645
222.85
1 year 133.53
Extreme 133.53
222.85
3 years 110.04
Extreme 110.035
270.5
5 years 110.04
Extreme 110.035
345.78
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
4/8/26 Sell

Director

-593 0.0004%
9/6/26 Free

Director

1,505 0.0010%
1/5/26 Fiscal year

Executive/Senior Manager

2,333 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-1.35%+0.79%+64.72%-17.56% 32.28B
-1.67%-4.78%+37.02%-4.42% 79.3B
-0.90%+2.39%-18.98%-35.69% 59.21B
-3.35%-4.92%+463.91%+21.22% 55.09B
-6.78%-4.19%-4.50%+28.86% 49.86B
-2.43%-2.35%+8.03%+163.45% 47.9B
-2.64%-2.69%+48.59%+91.84% 25.21B
-0.09%+4.98%+18.59%+209.35% 23.87B
-0.34%+1.35%+60.10%+122.64% 16.89B
+2.73%0.00%-0.48%+845.45% 16.17B
Average -1.37%-1.09%+67.70%+142.51% 40.58B
Weighted average by Cap. -1.79%-1.97%+79.59%+75.06%

Financials

2026 *2027 *
Net sales 10.44B 9B 8.44B 7.7B 14.51B 998B 14.55B 100B 39.05B 504B 39.21B 38.35B 1,670B 10.66B 9.18B 8.61B 7.86B 14.81B 1,019B 14.86B 102B 39.86B 514B 40.02B 39.15B 1,705B
Net income 953M 821M 770M 703M 1.32B 91.09B 1.33B 9.14B 3.56B 45.98B 3.58B 3.5B 152B 1.9B 1.64B 1.53B 1.4B 2.64B 182B 2.65B 18.2B 7.1B 91.63B 7.13B 6.98B 304B
Net Debt 4.94B 4.25B 3.99B 3.64B 6.86B 472B 6.88B 47.32B 18.46B 238B 18.53B 18.13B 790B 2.42B 2.09B 1.96B 1.78B 3.36B 231B 3.37B 23.2B 9.05B 117B 9.09B 8.89B 387B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
28/08/26 US$218.50 -1.35% 517,484
27/08/26 US$221.50 +0.19% 497,524
26/08/26 US$221.07 +0.14% 647,334
25/08/26 US$220.77 +1.21% 495,435
24/08/26 US$218.12 +0.62% 649,828
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
218.50USD
Average target price
236.22USD
Spread / Average Target
+8.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock